Search

Research

Advancing Medical Science Through Innovation and Collaboration

Gateway to Transformative Research

As a hub for scientific discovery, the University of Virginia’s School of Medicine (SOM) retains top-level researchers, who are doing pioneering work translating discoveries into lifesaving care.

With over $287 million in total research dollars and $181 million in National Institutes of Health research awards, the SOM is an internationally recognized leader in research that advances science, pioneers the treatments of tomorrow, and improves the health of all people on a global scale. We are shaping the future of medicine through innovation, collaboration, and excellence in research.

Revolutionizing the Future of Medicine

The University of Virginia School of Medicine’s commitment to advancing medical science is evident through its groundbreaking research that addresses some of the most complex medical problems of our age. Our world-class researchers are advancing the frontiers of science—developing transformative technologies such as the artificial pancreas for type 1 diabetes, leading breakthroughs in focused ultrasound treatments for Parkinson’s disease, and uncovering a revolutionary link between the brain and the immune system. These discoveries are reshaping our understanding of human health and paving the way for innovative treatments that improve lives around the world.

Learn About Our Research

Research Departments, Centers, and Core Facilities

Research in Motion

Ready to be inspired? In our Research in Motion video series, we asked scientists three questions about their research. Watch our top-notch, School of Medicine experts discuss the processes behind their work and celebrate their discoveries with them.

Watch the Videos

Paul and Diane Manning Institute of Biotechnology

This new initiative showcases UVA’s commitment to leading biotechnology research, placing UVA and UVA Health at the forefront of disease treatment and cures. The new institute will advance medicine in nanotechnology, small molecule therapeutics, gene and viral therapy, cellular therapy, and vaccine development. It will also include a cGMP manufacturing facility to produce human-grade therapeutics for testing in a state-wide clinical trials network.

Learn More